InCube Ventures is a US-based venture capital firm specializing in medical devices and life science investments. The firm focuses on disruptive healthcare technologies, targeting companies at various stages from seed to Series D. InCube Ventures typically invests in Series A and B rounds, with a particular emphasis on innovative approaches to chronic conditions and novel drug delivery methods.
Notable portfolio companies include Rani Therapeutics, developing oral delivery systems for peptides and proteins, and Fe3 Medical, working on iron-deficiency anemia treatments. The firm also backs Metagenomi in the genomics space and Tasso in blood collection technology. InCube Ventures offers value beyond capital, leveraging its expertise to support portfolio companies in navigating the complex healthcare landscape and accelerating their path to market.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Stage Mix
Concentration shown as share of disclosed investments by stage.
Classification
- Also Known As
- Incube Ventures, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
- Industry
- —Financial Services Companies
- —Investment Companies
- —Investment Management Companies
- —Private Equity Firms
- —Venture Capital Firms
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
